logo

For the Inventor, By the Inventor

Vincent C O Njar

Glen Burnie, MD, United States of America

Vincent C O Njar

LinkedIn
USPTO Granted Patents = 15 

 

Average Co-Inventor Count = 2.8

ph-index = 5

Forward Citations = 54(Granted Patents)


Location History:

  • Baltimore, MD (US) (2001 - 2002)
  • Columbia, MD (US) (2007)
  • Lansdale, PA (US) (2015)
  • Glen Burnie, MD (US) (2011 - 2023)

Company Filing History:

goldMedal15 out of 1,934 
 
University System of Maryland
 patents
silverMedal2 out of 6 
 
Tokai Pharmaceuticals, Inc.
 patents
bronzeMedal2 out of 2,104 
 
University of Washington
 patents
4. 1 out of 529 
 
Thomas Jefferson University
 patents
5. 1 out of 3,539 
 
The United States of America, As Represented by the Secretary, Department of Health and Human Services
 patents
where one patent can have more than one assignee

Years Active: 2001-2025

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 12391725 - Method for production of novel galeterone analogs and uses thereof (2025-08-19),
2. 11707468 - Methods of treating pancreatic cancer (2023-07-25),
3. 10675289 - Methods of treating pancreatic cancer (2020-06-09),
4. 10617685 - Nonsteroidal and steroidal compounds with potent androgen receptor down-regulation and anti prostate cancer activity (2020-04-14),
5. 10098896 - C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens, in vitro biological activities, pharmacokinetics and antitumor activity (2018-10-16),
6. 9884067 - Androgen receptor down-regulating agents and uses thereof (2018-02-06),
7. 9808472 - Biomarkers for treatment of neoplastic disorders using androgen-targeted therapies (2017-11-07),
8. 9694005 - Nonsteroidal and steroidal compounds with potent androgen receptor down-regulation and anti prostate cancer activity (2017-07-04),
9. 9439912 - Androgen receptor down-regulating agents and uses thereof (2016-09-13),
10. 9387216 - Biomarkers for treatment of neoplastic disorders using androgen-targeted therapies (2016-07-12),
11. 9156792 - Retinamide and uses thereof (2015-10-13),
12. 7960435 - Anti-cancer agents and androgen inhibition activity compound (2011-06-14),
13. 7265143 - C-4 substituted retinoids (2007-09-04),
14. 6444683 - 17-azolyl steroids useful as androgen synthesis inhibitors (2002-09-03),
15. 6200965 - 17-Azolyl steroids useful as androgren synthesis inhibitors (2001-03-13),

Title: The Innovative Journey of Vincent C O Njar

Introduction: Vincent C O Njar is a talented inventor based in Glen Burnie, MD (US) known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Vincent C O Njar holds several patents in various technological areas, including artificial intelligence, renewable energy, and medical devices.

Career Highlights: With a career spanning over two decades, Vincent C O Njar has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have revolutionized the industry.

Collaborations: Throughout his career, Vincent C O Njar has collaborated with top engineers, scientists, and researchers to bring his innovative ideas to life. His collaborative spirit has led to the successful implementation of numerous projects.

Conclusion: Vincent C O Njar's passion for innovation and his dedication to pushing the boundaries of technology make him a true pioneer in the field of inventions. His work continues to inspire the next generation of inventors and innovators worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…